Araştırma Makalesi

The relationship between free thyroid hormone index and thyrotoxicosis in pregnancy

Cilt: 42 Sayı: 1 20 Mayıs 2020
Cumhuriyet Tıp Dergisi Kapak
Cumhuriyet Tıp Dergisi
PDF İndir
EN

The relationship between free thyroid hormone index and thyrotoxicosis in pregnancy

Abstract

Objective: The aim of this study was to evaluate free thyroid hormone index (FTHI) (FT3 index/ FT4 index) as a parameter to use in differential diagnosis of gestational Graves’ disease (GGD) and gestational transient thyrotoxicosis (GTT). GGD and GTT are the most common causes of thyrotoxicosis in early pregnancy and differential diagnosis is important since they are treated differently. 
Method: Women who applied to our clinic with thyrotoxicosis were evaluated and 51 pregnant women were recruited to the study. Among the 51 women, 36 had GTT, 15 had GGD. The age, gestational age, thyroid stimulating hormone (TSH) levels, and FTHI (FT3 index / FT4 index) of all patients were recorded and compared. FT3/FT3 upper limit of normal (ULN) is referred as FT3 index. FT4 index is also referred as FT4/FT4 ULN. All diagnosis of GGD and GTT was confirmed with TRAb assays.
Results: The mean values of FT3, FT3 index, FTHI of the GGD group were found to be statistically significantly higher compared to GTT group (p: 0.002, p: 0.001, 0.001; respectively). No statistically significant difference was found between groups in terms of age, gestational age, FT4, FT4 index and TSH (p:0.999, p:0.730, p:0.620, p:0.570, p:0.291; respectively) FTHI values were above 1 in all patients with GGD while it was below 1 in GTT group. 
Conclusions: The FTHI values above 1 may be used as a practical, cheap parameter for differential diagnosis between GGD and GTT.

Keywords

Destekleyen Kurum

Destek alınmamıştır.

Proje Numarası

yok

Teşekkür

yok

Kaynakça

  1. 1. Krassas GE, Poppe K, Glinoer D. Thyroid function and human reproductive health. Endocr Rev 2010; 31: 702-55.
  2. 2. Galofre JC, Davies TF. Autoimmune thyroid disease in pregnancy: a review. J Womens Health (Larchmt) 2009; 18: 1847-56.
  3. 3. Niebyl JR. Clinical practice. Nausea and vomiting in pregnancy. N Engl J Med 2010; 16: 1544-50.
  4. 4. Verberg MF, Gillott DJ, Al-Fardan N, Grudzinskas JG. Hyperemesis gravidarum, a literature review. Hum Reprod Update 2005; 11: 527-39.
  5. 5. Gharib H, Tuttle RM, Baskin HJ, Fish LH, Singer PA, McDermott MT. Subclinical thyroid dysfunction: A joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and The Endocrine Society. J Clin Endocrinol Metab 2005; 90: 586-7.
  6. 6. Grigoriu C, Cezar C, Grigoras M, Horhoianu I, Parau C, Vîrtej P, Lungu A, Horhoianu V, Poiana C. Management of hyperthyroidism in pregnancy. J Med Life 2008; 1: 390-6.
  7. 7. David S Cooper, Peter Laurberg. Hyperthyroidism in pregnancy. Lancet Diabetes Endocrinol 2013; 1: 238-49.
  8. 8. Luewan S, Chakkabut P, Tongsong T. Outcomes of pregnancy complicated with hyperthyroidism:a cohort study. Arch Gynecol Obstet 2011; 283: 243-7.

Ayrıntılar

Birincil Dil

İngilizce

Konular

Sağlık Kurumları Yönetimi

Bölüm

Araştırma Makalesi

Yazarlar

Yayımlanma Tarihi

20 Mayıs 2020

Gönderilme Tarihi

6 Mayıs 2020

Kabul Tarihi

13 Mayıs 2020

Yayımlandığı Sayı

Yıl 2020 Cilt: 42 Sayı: 1

DOI

https://doi.org/10.7197/cmj.vi.732979

IZ

https://izlik.org/JA24FH97JZ

Kaynak Göster

RIS / Bibtex
AMA
1.Acıbucu F, Uysal G, Bankir M. The relationship between free thyroid hormone index and thyrotoxicosis in pregnancy. CMJ. 2020;42(1):94-99. doi:10.7197/cmj.vi.732979

Cited By

Advances in the differential diagnosis of transient hyperthyroidism in pregnancy and Graves’ disease

Archives of Gynecology and Obstetrics

https://doi.org/10.1007/s00404-022-06774-z